课题基金 / 基金详情

MATERNAL AND NEONATAL IMMUNITY

MATERNAL AND NEONATAL IMMUNITY
母体和新生儿的免疫力
批准号:
6387478
负责人:
THOMAS B TOMASI
金额:
$30.87万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-01 至 2002-07-18

项目摘要

项目成果

THOMAS B TOMASI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The failure of the trophoblast to express MHC class II antigens is believed to be essential for survival of the fetus during pregnancy. It is therefore likely that strong evolutionary pressures to preserve reproduction would develop tight overlapping regulatory controls. We have identified two such control mechanisms which inhibit trophoblast class II expression. An upstream negative regulatory element (IAalphaNRE) in the promoter of the murine class II IAalpha gene that represses transcription specifically in trophoblasts. In addition, the class II transcription activator (CIITA), the master regulator of class II expression is not transcribed in trophoblast cells, nor can it be induced by IFN-gamma or other cytokines that upregulate class II in most other cell types. The goals of this grant are to further define the underlying mechanisms responsible for the inability of the trophoblast to express class II and the physiological relevance of this to fetal persistence. Hopefully, these studies will also elucidate fundamental control mechanisms for class II expression that have application to other areas of clinical relevance such as cancer and autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
Epigenetic Regulation of Immune Genes in Cancer Treatment and Vaccine Protocols
海外基金